Actively Recruiting
Comparative Evaluation of Telehealth Multi-Component Optional Model (MOM) of Postpartum Care Among Rural, Low-income, and Diverse Women
Led by University of Arkansas · Updated on 2026-02-05
1500
Participants Needed
6
Research Sites
47 weeks
Total Duration
On this page
Sponsors
U
University of Arkansas
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating two postpartum care models for diverse women, including those from racial minority groups and rural areas, to determine which approach best supports timely identification and treatment of postpartum complications. This randomized controlled trial compares a new Telehealth Multi-Component Optional Model (Telehealth MOM) with an enhanced standard of care. The study focuses on improving comprehensive postpartum care and meeting the specific needs and preferences of women after childbirth. Participants will be assigned to one of two groups. The Telehealth MOM group will receive education, an in-person visit around 6 weeks postpartum, plus additional care, along with a remote blood pressure cuff and thermometer to monitor vital signs twice daily for 14 days after hospital discharge. A nurse will monitor these readings and conduct an early telehealth visit between 10 and 14 days postpartum. The enhanced standard of care group will receive education and an in-person postpartum visit around 6 weeks, with further care as needed. During the study, participants' adherence to the monitoring schedule and engagement with the telehealth visits will be tracked. Researchers will measure the completion rate of the 6-week comprehensive postpartum visit. Safety and participant outcomes will be monitored throughout the postpartum period. The total study duration extends to the 6-week postpartum visit, with follow-up care coordinated as necessary to support maternal health.
CONDITIONS
Brief Title
Telehealth Multi-Component Optional Model (MOM) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women between 16 and 35 weeks gestation
- Age between 18 and 44 years
- Ability to speak English, Spanish, or Marshallese
- Participants may have either a vaginal birth or cesarean section birth
You will not qualify if you...
- Type 1 diabetes on an insulin pump followed closely by endocrinology
- Uncontrolled Type 2 diabetes
- End stage renal disease followed closely by nephrology
- ICU admission at any point during pregnancy or delivery hospitalization
- Other maternal conditions requiring additional surgeries (e.g., cesarean hysterectomy, intrapartum or postpartum oophorectomy/appendectomy)
- Incarceration
- Mental disability limiting decision-making capacity
- Uncontrolled chronic hypertension
- HELLP syndrome during pregnancy
- Sickle cell disease
- Maternal heart condition or heart disease
- Opioid use disorder
- Lupus
- Thrombophilia or blood clots
- Need for blood transfusion during delivery hospitalization
- Other maternal conditions or complications requiring prolonged hospitalization postpartum, known during pregnancy or delivery hospitalization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 days for remote monitoring plus up to 6 weeks until comprehensive postpartum visit
Participants will receive either enhanced standard of care or the Telehealth Multi-Component Optional Model (MOM) which includes remote blood pressure and temperature monitoring plus a telehealth visit 10 to 14 days postpartum.
Telehealth MOM arm: daily remote monitoring and 1 telehealth visit between 10 to 14 days postpartum; Enhanced Standard of Care arm: 1 comprehensive postpartum visit around 6 weeks postpartum
Trial Site Locations
Total: 6 locations
1
UAMS El Dorado FMC
El Dorado, Arkansas, United States, 71730
Not Yet Recruiting
2
UAMS Fayetteville FMC
Fayetteville, Arkansas, United States, 72703
Actively Recruiting
3
UAMS Fort Smith FMC
Fort Smith, Arkansas, United States, 72901
Actively Recruiting
4
UAMS Jonesboro FMC
Jonesboro, Arkansas, United States, 72401
Not Yet Recruiting
5
UAMS Health Women's Center
Little Rock, Arkansas, United States, 72205
Actively Recruiting
6
UAMS Springdale FMC
Springdale, Arkansas, United States, 72764
Actively Recruiting
Research Team
B
Brett Rowland, MA
K
Kacie Simpson, BS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here